Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department

Journal of the American Geriatrics Society

Volumn 58, Issue 3, 2010, Pages 518-522

  Lai, Chih Cheng ^a   Chen, Shey Ying ^b   Wang, Cheng Yi ^a   Wang, Jen Yu ^a   Su, Chan Ping ^c   Liao, Chun Hsing ^b   Tan, Che Kim ^d   Huang, Yu Tsung ^b   Lin, Hen I ^a   Hsueh, Po Ren ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Bacteremia; Bacterial infection; Elderly; Procalcitonin; Systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ABDOMINAL INFECTION; AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CATHETER INFECTION; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EMERGENCY WARD; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; SOFT TISSUE INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

AGED; BACTEREMIA; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77949366396     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02730.x     Document Type: Article

References (24)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
2. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
3. Kollef MH, Sherman G, Ward S et al. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474.
4. Le Moullec JM, Jullienne A, Chenais J et al. The complete sequence of human preprocalcitonin. FEBS 1984;167:93-97.
5. Ugarte H, Silva E, Mercan D et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504.
6. Muller B, Becker KL, Schachinger H et al. Calcitonin precursors are reliable markers of sepsis in amedical intensive care unit. Crit Care Med 2000;28:977-983.
7. Assicot M, Gendrel D, Carsin H et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
8. Hausfater P, Garric S, Ayed SB et al. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study. Clin Infect Dis 2002;34:895-901.
9. Claeys R, Vinken S, Spapen H et al. Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates. Crit Care Med 2002;30:757-762.
10. Gendrel D, Raymond J, Coste J et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999;18:875-881.
11. Müller B, Becker KL. Procalcitonin: How a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001;131:595-602.
12. Fraunberger P, Wang Y, Holler E et al. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006;26:10-12.
13. Harbarth S, Holeckova K, Froidevaux C et al. Diagnostic value of procalcitonin, interleukin- 6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
14. Aikawa N, FujiAikawa N, Fujishima S et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005;11:152-159.
15. Brunkhorst FM, Wegscheider K, Forycki ZF et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intens Care Med 2000;26:S148-S152.
16. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002;20:1-9.
17. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29.
18. Simon L, Gauvin F, Amre DK et al. Serumprocalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
19. Caterino JM, Scheatzle MD, Farbes ML et al. Bacteremic elderly emergency department patients: Procalcitonin and white count. Acad Emerg Med 2004;11:393-396.
20. Stucker F, Herrmann F, Graf JD et al. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005;553:1392-1395.
21. Holm A, Pedersen SS, Nexoe J et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007;57:555-560.
22. Smolkin V, Koren A, Raz R et al. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol 2002;17:409-412.
23. Pecile P, Miorin E, Romanello C et al. Procalcitonin: A marker of severity of acute pyelonephritis among children. Pediatrics 2004;114:e249-e254.
24. El Solh AA, Aquilina AT, Gunen H et al. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc 2004; 52:224-229.